Pediatric exclusivity was sold as a shield. In practice, its often a fuseburning time, incentives, and patient access faster than the market can adapt.
For years, the U.S. pediatric exclusivity framework has been framed as a win-win: encourage companie…

Bausch Health vs. Sun Pharma: When Patent Strategy Meets the Reality of Settlement Leverage
A case study in how patent litigation can be less about winning in courtand more about shaping outcomes before a judge ever weighs in.
Bausch Health Companies I…

Exelixis v. Intas: The Patent Fight Behind a Multibillion-Dollar Oncology Play
If you think generic competition is the biggest threat to blockbuster oncology drugs, think again. The real battlefield is often the patent landscapeand the next round of le…

Big pharma litigation isnt just about who wins a courtroomit’s about who gets to set the clock.
In the case of Amneal Pharmaceuticals LLC v. Alembic Pharmaceuticals Ltd., the dispute at the heart of DrugPatentWatchs coverage underscores a reality many …

Exelixis v. Handa: The Patent Fight That Will Shape the Next Wave of Oncology Competition
In pharma, timing is destinyand nowhere is that clearer than in the recent litigation spotlighting Exelixis, Inc. v. Handa Pharmaceuticals. If youre an investor, …

Takeda v. Sun Pharma: The quiet battleground beneath patent win headlines
In courtrooms and conference rooms, patent litigation is often described as a binary event: win or lose. But the real storyespecially in Hatch-Waxman and biosimilar-era disputesi…

A courtroom fight doesnt usually show up on your dashboarduntil it does.
In patent litigation, the battle is often framed as legal doctrine, but the real impact lands in timelines, access, and pricing. A recent example: AzuRity Pharmaceuticals, Inc. v….

Vertex Pharmaceuticals v. Squires: The Quiet Legal Shift That Could Reshape Pharmas Playbook
In patent law, the loud cases are the ones that hit headlines. The more consequential ones often move in smaller incrementsthrough procedural decisions, claim …

Are you looking for Adefovir dipivoxil (brand Hepsera) and want info about a discount card (copay savings / patient savings… https://www.Drugchatter.com/chat/59984/adefovir-dipivoxil-discount-card/

Brand patent crumbling isnt luck. Its signals. Heres how to read them.
In patent litigation, everyone loves a good storyline: a weak claim meets a clever challenger, a judge spots the problem, andboombrand patents fall.
But the market reality is less c…